Medical Properties Trust, Inc.(MPT)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL
1-STAR RATING
PASS
LAST CLOSE
$1.67
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for MPT

11/13/2026: MPT (1-star) is currently NOT-A-BUY. Pass it for now.

Medical Properties Trust, Inc. is a specialized real estate investment trust focused on the acquisition and leasing of hospital facilities globally. The company's business model relies on long-term net leases with hospital operators, which has historically provided stable, predictable cash flows. However, the firm currently faces significant challenges due to high financial leverage and the credit difficulties of key tenants, particularly Steward Health Care. The primary investment story centers on its ongoing deleveraging efforts and portfolio stabilization. The stock is generally suited for investors comfortable with high volatility, as the company navigates complex tenant risks and interest rate pressures, necessitating close monitoring of balance sheet improvements.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorWeak fitThe company is currently in a defensive, deleveraging phase rather than an aggressive growth cycle.
Momentum investorWeak fitThe stock has faced significant downward pressure and structural concerns, lacking a positive momentum signal.
Value investorMixed fitWhile the stock may appear inexpensive on some metrics, the valuation reflects material risks regarding tenant solvency.
Dividend investorMixed fitHistorical dividends were high, but recent cuts and ongoing financial restructuring make income stability less certain.
Low-risk investorWeak fitThe company's high leverage and tenant-specific risks result in a volatility profile unsuitable for low-risk portfolios.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityHighThe stock has experienced extreme fluctuations due to market sentiment regarding tenant creditworthiness.
Valuation riskMedium / highUncertainty regarding the true value of assets during tenant transition or liquidation poses a risk to net asset value.
Competition risk (Tenant concentration)HighHeavy reliance on a few key hospital operators makes the firm vulnerable to specific tenant business failures.
Business qualityMediumWhile the underlying hospital assets are essential, the business model is currently pressured by balance sheet constraints.
Dividend incomeMedium / highRecent dividend adjustments reflect the necessity of retaining cash to manage debt obligations.
Execution riskHighSuccessfully divesting assets at fair prices to deleverage the balance sheet is critical for long-term viability.

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 983.46M USD
Price to earnings Ratio 3.98
1Y Target Price 3.55
Price to earnings Ratio 3.98
1Y Target Price 3.55
Volume (30-day avg) 19.5M shares
Beta 1.55
52 Weeks Range 1.62 - 6.09
Updated Date 11/14/2026
52 Weeks Range 1.62 - 6.09
Updated Date 11/14/2026
Dividends yield (FY) 21.05%
Basic EPS (TTM) 0.42

Sector & Industry Intelligence

Sector

Real Estate

Constructive
Sentiment
Strong Bullish
Momentum
BUY Breadth Improving
BUY participation
64.5%
Active BUY / eligible
20 / 31
30-Day BUY Count Change
+16
Market state
Strong Bullish

More qualifying stocks are receiving or maintaining BUY advisories, indicating improving market participation.

Industry

REIT - Healthcare Facilities

BUY participation
100.0%
Active BUY / eligible
4 / 4
30-Day BUY Count Change
+4

Eligible universe: 4 stocks.

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Steep Decline
PRICE PATH

Steep Decline

The stock price has dropped sharply with strong downward pressure.

Choppy
PRICE STABILITY

Choppy

The stock has experienced frequent reversals and pronounced short-term price swings.

Analysis of Past Performance

Type Stock
Historic Profit -4.52%
Avg. Invested days 34
Today’s Advisory PASS
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 2.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
MPT receives a 3-star rating, supported by solid unit economics, and solid company fundamentals. The rating is constrained by weak price momentum.

Company Fundamentals

★★★★★
MPT has solid overall fundamentals (4 stars), with solid financial health, solid growth momentum, and solid ownership. In FY2025 versus FY2024, strong earnings growth (+88.5%) and strong cash generation (FCF margin 23.7%) are partially offset by slightly negative revenue growth (-2.4%), weak profitability (net margin -28.5%).

Financial Health Rating

★★★★★
MPT's financial health is supported by solid efficiency, including operating-expense and cost-of-revenue discipline (opex 40.7% of revenue). Liquidity is moderate (3 stars), which helps explain the 4-star overall score.

Growth Momentum Score

★★★★★
Earnings growth is MPT's strongest growth driver at +88.5% FY2025 versus FY2024 (strong, 5 stars). By comparison, while revenue growth (-2.4%, slightly negative) and free-cash-flow growth (-6.0%, negative) hold the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 62.4% and approximately 81.8% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 9.45% supports management-shareholder alignment.

Top 5 Institutional Investors

BlackRock Inc 12.60%
Vanguard Portfolio Management, LLC 7.33%
State Street Corp 4.21%
Vanguard Capital Management, LLC 3.64%
AQR Capital Management LLC 2.95%

Unit Economics (Per $1K Revenue)

★★★★★
MPT generates approximately $963 of gross profit, $555 of operating income, and $237 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Strong margins and weak cash conversion support the rating, although capital efficiency remains weak.

Economic Dimensions

★★★★★
Effective Tax Rate: -16.27% (Tax Credit)

Quantitative Style Profile

★★★★★
MPT has a liquid profile. Weak momentum is the primary drawback, while elevated volatility.

Style Classification

Quality Focused

Value-OrientedHigh VolatilitySmall / Mid Cap RiskShort Squeeze RiskHighly Liquid / Institution-Friendly

How Company Makes Money

Business areaWhat it includesRetail investor read
Hospital LeasingRental income from long-term, triple-net leases on hospital facilities.The company acts as a landlord for hospitals and collects steady rent from the operators.
Mortgage/Loan FinancingInterest income from loans provided to healthcare operators.The company also functions as a lender, earning interest from the hospital businesses they support.

Analyzing Revenue: Products, Geography and Growth

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date 2026-10-29
When Before Market
Estimate 0.13
Actual 0.11

Profitability

Profit Margin 22.85%
Operating Margin (TTM) 59.7%

Management Effectiveness

Return on Assets (TTM) 2.78%
Return on Equity (TTM) 5.4%

Valuation

Trailing PE 3.98
Forward PE 6.67
Enterprise Value 9.76B
Price to Sales(TTM) 0.9
Enterprise Value 9.76B
Price to Sales(TTM) 0.9
Enterprise Value to Revenue 9.46
Enterprise Value to EBITDA 7.19
Shares Outstanding 588.90M
Shares Floating 481.62M
Shares Outstanding 588.90M
Shares Floating 481.62M
Percent Insiders 9.45
Percent Institutions 62.43

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.